SAS Output

20-AUG-2018 6:10

GI ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1613-mCRC, Adv/Met, TP vs CETIRI 1 Y 0 Screening 130 63 63 53 36 11 1 11/27/2017 323 127
            63 63 53 36 11 1      
 
    2 Y 1 Trastuzumab + Pertuzumab 130 4 4 4 2 0 0 11/27/2017    
        2 Cetuximab + Irinotecan   4 4 4 3 0 0      
            8 8 8 5 0 0      
 
    3 Y 3 Crossover: Trastuz + Pertuz 130 1 1 1 1 1 1 11/27/2017    
            1 1 1 1 1 1      
 
Yes A021502-Colon, Stg III, Chemo +/- Atezol, ATOMIC 1 E Total Registrations   5 5 5 1 0 0 03/23/2018 72 34
            5 5 5 1 0 0      
 
  N1048-Rectal,LocalAdv,ChemoRT+/-FOLFOX 1 E Total Registrations   156 29 14 7 1 0 06/05/2013 354 161
            156 29 14 7 1 0      
 
No A021501-Adeno Panc,Borderline Resect,Chemo vs ChemoRT 0 E Total Registrations   18 13 4 0 0 0 05/01/2017 218 84
            18 13 4 0 0 0      
 
    1 E Total Registrations   15 11 3 0 0 0 05/01/2017    
            15 11 3 0 0 0      
 
  EA2142-GI NEC, Adv G3, EP vs TMZ + CAP 1 E Total Registrations   4 1 0 0 0 0 07/14/2016 183 74
            4 1 0 0 0 0      
 
  NRGGI002-Rectal, Ph II, Sensitization using TNT 1 E Total Registrations   6 4 0 0 0 0 02/21/2017 331 141
            6 4 0 0 0 0      
 
  NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy 1 E Total Registrations   2 2 2 1 1 0 04/18/2018 76 28
            2 2 2 1 1 0